HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsVelia Chiara Di Maio, Antonio Di Biagio, C. Sarrecchia et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 13
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Francesca Ceccherini‐Silberstein, Daniele Di Paolo et al.|Digestive and Liver Disease|2014Cited by 5
In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype AssignmentM. Aragri, Giustino Parruti, Velia Chiara Di Maio et al.|Journal of Hepatology|2016Cited by 1
P1235 BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORSValeria Cento, Francesca Ceccherini‐Silberstein, Velia Chiara Di Maio et al.|Journal of Hepatology|2014Cited by 0
Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitorsValeria Cento, Francesca Ceccherini‐Silberstein, F.P. Antonucci et al.|Digestive and Liver Disease|2014Cited by 0